|
Alesci S, Bornstein SR. Neuroimmunoregulation of androgens in the adrenal gland
and the skin. Horm.Res 2000;54:281 6.
Arlt W, Callies F, Allolio B. DHEA replacement in women with adrenal insufficiency
pharmakinetics, bioconversion and clinical effects on well being, sexuality
and cognition. Endocr Res.2000;26(4):505 11.
Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler
D, Oettel M, Ernst M, Schulte HM, Allolio B.Dehydroepiandrosterone replacement
in women with adrenal insufficiency. N Engl J Med. 1999 Sep 30;341(14):1013
20.
Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt
W, Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency:
effects on body composition, serum leptin, bone turnover, and exercise capacity.
J Clin Endocrinol Metab. 2001 May;86(5):1968 72.
Cameron DR, Braunstein GD. Androgen replacement therapy in women. Fertil Steril.
2004;82(2):273 89.
Ceschel GC, Mora PC, Lombardi BS, Maffei P, Ronchi C. Skin permeation study
of Dehydroepiandrosterone (DHEA) compared with its alpha cyclodextrin complex
form. J Pharm Sci 2002;91:2399 407.
Minghetti P, Cilurzo F, Casiraghi A, Montanari L, Santoro A Development of
patches for the controlled release of Dehydroepiandrosterone. Drug Dev.Ind Pharm
2001;27:711 7.
Spark RF. Dehydroepiandrosterone: a springboard hormone for female sexuality.
Fertil Steril. 2002;77:S19 25.
Villareal D, Holloszy J. Effect of DHEA on abdominal fat and insulin action
in elderly women and men. JAMA 2004;292(18):2243 8.
|